NEVVI Medicare utilization intelligence

← back

IBRAHIM, MOHAMMEDMD NPI 1891701082 Clinician

Hematology-Oncology · ROYAL OAK, MI

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 25 years since medical school (class of 2001, self-reported to CMS)
Location ROYAL OAK, MI · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 49 codes billed · 72,000 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MICHIGAN HEALTHCARE PROFESSIONALS PC
2019–2026
BEAUMONT MEDICAL GROUP- SPECIALTY SERVICES
2022
MCLAREN OAKLAND
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2019-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1453 Injection, fosaprepitant, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
84100 Phosphate level
84550 Uric acid level, blood
83615 Lactate dehydrogenase (enzyme) level
96413 Administration of chemotherapy into vein, 1 hour or less
80048 Blood test, basic group of blood chemicals (calcium, total)
83735 Magnesium level
80076 Liver function blood test panel
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J9045 Injection, carboplatin, 50 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96417 Administration of additional new drug or substance into vein, 1 hour or less
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96360 Infusion into a vein for hydration, 31-60 minutes
96415 Administration of chemotherapy into vein, each additional hour
J3475 Injection, magnesium sulfate, per 500 mg
J3489 Injection, zoledronic acid, 1 mg
96361 Infusion into a vein for hydration, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
J3490 Unclassified drugs
99195 Drawing of blood for a medical problem
80053 Blood test, comprehensive group of blood chemicals
96374 Injection of drug or substance into vein
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99496 Transitional care management services for problem of high complexity
96523 Irrigation of implanted venous access drug delivery device

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.